Tambussi G - Search Results

1

Oral CCR5 inhibitors: will they make it through?

Biswas P, Nozza S, Scarlatti G, Lazzarin A, Tambussi G. Biswas P, et al. Among authors: tambussi g. Expert Opin Investig Drugs. 2006 May;15(5):451-64. doi: 10.1517/13543784.15.5.451. Expert Opin Investig Drugs. 2006. PMID: 16634684 Review.

2

Persistence of CCR5 usage among primary human immunodeficiency virus isolates of individuals receiving intermittent interleukin-2.

Ghezzi S, Pacciarini F, Nozza S, Racca S, Mariani SA, Vicenzi E, Lazzarin A, Veglia F, Tambussi G, Poli G. Ghezzi S, et al. Among authors: tambussi g. HIV Med. 2010 May;11(5):349-52. doi: 10.1111/j.1468-1293.2009.00782.x. Epub 2009 Dec 8. HIV Med. 2010. PMID: 20015219 Free article. Clinical Trial.

3

Access denied? The status of co-receptor inhibition to counter HIV entry.

Biswas P, Tambussi G, Lazzarin A. Biswas P, et al. Among authors: tambussi g. Expert Opin Pharmacother. 2007 May;8(7):923-33. doi: 10.1517/14656566.8.7.923. Expert Opin Pharmacother. 2007. PMID: 17472538 Review.

4

Does cyclosporin A affect CCR5 and CXCR4 expression in primary HIV-1-infected patients?

Biswas P, Galli A, Galli L, Tassan Din C, Vecchi A, Malnati M, Lazzarin A, Tambussi G. Biswas P, et al. Among authors: tambussi g. Cytometry B Clin Cytom. 2007 Nov;72(6):433-41. doi: 10.1002/cyto.b.20352. Cytometry B Clin Cytom. 2007. PMID: 17474134 Free article. Clinical Trial.

5

Tumor necrosis factor alpha, interleukin 2, and soluble interleukin 2 receptor levels in human immunodeficiency virus type 1-infected individuals receiving intermittent cycles of interleukin 2.

Fortis C, Soldini L, Ghezzi S, Colombo S, Tambussi G, Vicenzi E, Gianotti N, Nozza S, Veglia F, Murone M, Lazzarin A, Poli G. Fortis C, et al. Among authors: tambussi g. AIDS Res Hum Retroviruses. 2002 May 1;18(7):491-9. doi: 10.1089/088922202317406637. AIDS Res Hum Retroviruses. 2002. PMID: 12015902 Clinical Trial.

6

Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy.

Malnati M, Broccolo F, Nozza S, Sarmati L, Ghezzi S, Locatelli G, Delfanti F, Capiluppi B, Careddu A, Andreoni M, Monini P, Poli G, Lazzarin A, Lusso P, Tambussi G. Malnati M, et al. Among authors: tambussi g. Blood. 2002 Sep 1;100(5):1575-8. Blood. 2002. PMID: 12176873 Free article.

7

Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.

Furci L, Scarlatti G, Burastero S, Tambussi G, Colognesi C, Quillent C, Longhi R, Loverro P, Borgonovo B, Gaffi D, Carrow E, Malnati M, Lusso P, Siccardi AG, Lazzarin A, Beretta A. Furci L, et al. Among authors: tambussi g. J Exp Med. 1997 Aug 4;186(3):455-60. doi: 10.1084/jem.186.3.455. J Exp Med. 1997. PMID: 9236198 Free PMC article.

8

CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.

Lopalco L, Barassi C, Pastori C, Longhi R, Burastero SE, Tambussi G, Mazzotta F, Lazzarin A, Clerici M, Siccardi AG. Lopalco L, et al. Among authors: tambussi g. J Immunol. 2000 Mar 15;164(6):3426-33. doi: 10.4049/jimmunol.164.6.3426. J Immunol. 2000. PMID: 10706739

9

Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience.

Nozza S, Galli L, Visco F, Soria A, Canducci F, Salpietro S, Gianotti N, Bigoloni A, Torre LD, Tambussi G, Lazzarin A, Castagna A. Nozza S, et al. Among authors: tambussi g. AIDS. 2010 Mar 27;24(6):924-8. doi: 10.1097/QAD.0b013e3283372d76. AIDS. 2010. PMID: 20154578

10

Levels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patients.

Nozza S, Pogliaghi M, Chiappetta S, Spagnuolo V, Fontana G, Razzari C, Tambussi G, Faioni EM. Nozza S, et al. Among authors: tambussi g. PLoS One. 2012;7(6):e37032. doi: 10.1371/journal.pone.0037032. Epub 2012 Jun 8. PLoS One. 2012. PMID: 22715361 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page